AU2001247533A1 - Functional radiographic imaging methods and agents - Google Patents

Functional radiographic imaging methods and agents

Info

Publication number
AU2001247533A1
AU2001247533A1 AU2001247533A AU4753301A AU2001247533A1 AU 2001247533 A1 AU2001247533 A1 AU 2001247533A1 AU 2001247533 A AU2001247533 A AU 2001247533A AU 4753301 A AU4753301 A AU 4753301A AU 2001247533 A1 AU2001247533 A1 AU 2001247533A1
Authority
AU
Australia
Prior art keywords
agents
radiographic imaging
imaging methods
functional
functional radiographic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001247533A
Inventor
Nick Cairns
Jesse Salb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Veritas Pharmaceuticals Inc
Original Assignee
Veritas Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veritas Pharmaceuticals Inc filed Critical Veritas Pharmaceuticals Inc
Publication of AU2001247533A1 publication Critical patent/AU2001247533A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/48—Diagnostic techniques
    • A61B6/482—Diagnostic techniques involving multiple energy imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/40—Arrangements for generating radiation specially adapted for radiation diagnosis
    • A61B6/4035—Arrangements for generating radiation specially adapted for radiation diagnosis the source being combined with a filter or grating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/40—Arrangements for generating radiation specially adapted for radiation diagnosis
    • A61B6/4064—Arrangements for generating radiation specially adapted for radiation diagnosis specially adapted for producing a particular type of beam
    • A61B6/4092—Arrangements for generating radiation specially adapted for radiation diagnosis specially adapted for producing a particular type of beam for producing synchrotron radiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
AU2001247533A 2000-03-16 2001-03-15 Functional radiographic imaging methods and agents Abandoned AU2001247533A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19032300P 2000-03-16 2000-03-16
US60/190,323 2000-03-16
PCT/US2001/008612 WO2001068151A2 (en) 2000-03-16 2001-03-15 Functional radiographic imaging methods and agents

Publications (1)

Publication Number Publication Date
AU2001247533A1 true AU2001247533A1 (en) 2001-09-24

Family

ID=22700866

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001247533A Abandoned AU2001247533A1 (en) 2000-03-16 2001-03-15 Functional radiographic imaging methods and agents

Country Status (3)

Country Link
EP (1) EP1263478A2 (en)
AU (1) AU2001247533A1 (en)
WO (1) WO2001068151A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010046796A1 (en) * 2008-10-23 2010-04-29 Koninklijke Philips Electronics, N.V. Molecular imaging
EP3284739A1 (en) 2017-07-19 2018-02-21 Bayer CropScience Aktiengesellschaft Substituted (het) aryl compounds as pesticides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1263324B1 (en) * 2000-03-16 2009-12-02 Veritas Pharmaceuticals Radiographic assessment of tissue response to compounds

Also Published As

Publication number Publication date
EP1263478A2 (en) 2002-12-11
WO2001068151A3 (en) 2002-10-10
WO2001068151A2 (en) 2001-09-20

Similar Documents

Publication Publication Date Title
AU2001252504A1 (en) Combined impedance imaging and mammography
AU2001243710A1 (en) Imaging stretcher
EP1187075B8 (en) Human body detector
AU2001223932A1 (en) Encapsulated medical imaging device and method
AU4082801A (en) Imaging apparatus
AU2002245629A1 (en) Stabilized therapeutic and imaging agents
AU2001273505A1 (en) Single-use radiological imaging aid
AU2001278319A1 (en) Amyloid targeting imaging agents and uses thereof
EP1313477A4 (en) Compounds and methods
EP1274424A4 (en) Compounds and methods
AU2883702A (en) Cytological imaging systems and methods
AU5468301A (en) Ablation and imaging catheter
AU2002221381A1 (en) Imaging device
EP1075215A4 (en) Hyaluronan-based imaging agents
AU2000268695A1 (en) Imaging apparatus
AU2001243394A1 (en) Compounds and methods
AU7379700A (en) Multipurpose medical device
AU2002233979A1 (en) Skin perfusion evaluation apparatus
AU2002228725A1 (en) Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds
AUPQ872300A0 (en) Compounds and methods
AU5378400A (en) Radiopharmaceuticals and methods for imaging
AU2002210916A1 (en) Endoscope attachment and endoscope
AU2001285282A1 (en) Imaging device and method
AU2001278951A1 (en) Compounds and methods
AU4432001A (en) Trityl-type compounds and their use